ERCC1 Codon 118 Polymorphism Is a Useful Prognostic Marker in Patients With Pancreatic Cancer Treated With Platinum-Based Chemotherapy

International Journal of Oncology - Greece
doi 10.3892/ijo.32.5.1091
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

ERCC1 mRNA Expression Is Associated With the Clinical Outcome of Non-Small Cell Lung Cancer Treated With Platinum-Based Chemotherapy

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2014English

Timing of Chemotherapy-Induced Neutropenia: The Prognostic Factor in Advanced Pancreatic Cancer Patients Treated With Gemcitabine / Gemcitabine-Based Chemotherapy

Oncotarget
Oncology
2017English

Pretreatment Systemic Inflammation Response Index in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy as a Useful Prognostic Indicator

Cancer Management and Research
Oncology
2020English

Correlation of ERCC1 Expression in Peripheral Blood Lymphocytes With Outcomes of Patients With Gastric Cancer Treated With Oxaliplatin-Based Adjuvant Chemotherapy

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2015English

TP53 Codon 72 Polymorphism Is Associated With Pancreatic Cancer Risk in Males, Smokers and Drinkers

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2011English

The Addition of Postoperative Chemotherapy Is Associated With Improved Survival in Patients With Pancreatic Cancer Treated With Preoperative Therapy

Annals of Surgical Oncology
OncologySurgery
2015English

P53 Codon 72 Polymorphism Predicts the Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2005English

Tumor Size and Overall Survival in Patients With Platinum-Resistant Ovarian Cancer Treated With Chemotherapy and Bevacizumab

Clinical Medicine Insights: Oncology
Oncology
2019English

Overexpression of Filamin-A Protein Is Associated With Aggressive Phenotype and Poor Survival Outcomes in NSCLC Patients Treated With Platinum-Based Combination Chemotherapy

Neoplasma
Cancer Research
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy